All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Bioequivalence Study Of Rosiglitazone Maleate 2 mg Tablets On Twelve Indian Human Male Volunteers

Author(s): Mary Francis, A. A Moghe, S. R Pawar, S. S Khedkar

Rosiglitazone is a second-generation aminopyridyl thiazolidinedione that has been observed to be a safe and effective oral glucose-lowering agent in diabetic patients. In the present study two different preparations containing 2 mg rosiglitazone were compared in twelve healthy Indian human male volunteers under fasting condition. The trial was performed in a randomized two-way crossover design with a wash out period of one week. Rosiglitazone was extracted from human plasma using liquid-liquid method of extraction. HPLC method was used to determine the plasma concentration of the drug.